APA (7th ed.) Citation

HV, N., M, B., J, R., M, K., Y, L., & EB, S. (2010). Analysis of imatinib and sorafenib binding to p38alpha compared with c-Abl and b-Raf provides structural insights for understanding the selectivity of inhibitors targeting the DFG-out form of protein kinases. Biochemistry, 49(17), 3611. https://doi.org/10.1021/bi100070r

Chicago Style (17th ed.) Citation

HV, Namboodiri, Bukhtiyarova M, Ramcharan J, Karpusas M, Lee Y, and Springman EB. "Analysis of Imatinib and Sorafenib Binding to P38alpha Compared with C-Abl and B-Raf Provides Structural Insights for Understanding the Selectivity of Inhibitors Targeting the DFG-out Form of Protein Kinases." Biochemistry 49, no. 17 (2010): 3611. https://doi.org/10.1021/bi100070r.

MLA (9th ed.) Citation

HV, Namboodiri, et al. "Analysis of Imatinib and Sorafenib Binding to P38alpha Compared with C-Abl and B-Raf Provides Structural Insights for Understanding the Selectivity of Inhibitors Targeting the DFG-out Form of Protein Kinases." Biochemistry, vol. 49, no. 17, 2010, p. 3611, https://doi.org/10.1021/bi100070r.